Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q4 2024 Earnings

31OctConfirmed

Q1 2024

Q2 2024

Q3 2024

Q4 2024

-6.27

-4.43

-2.59

-0.75

Details

Expected EPS

-5.306720353799999

Actual EPS

-5.036778

Surprise EPS

0.27

Surprise Percent

+5.09%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -5.036778 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.